Sticker Shock: Company Must Pay $1.6 Billion for False Claims, Misbranding for Schizophrenia Drug Risperdal
Yet another large pharmaceutical company has found itself spanked with a huge fine over illegal marketing and sales practices involving medications that generated huge profits for the business.
Janssen Pharmaceuticals (JPI), a subsidiary of corporate giant Johnson & Johnson, pleaded guilty and agreed to pay more than $1.67 billion in criminal fines and civil settlements over the way it peddled Risperdal (risperidone), an FDA-approved medication for treatment of schizophrenia.
On another legal front, the company is defending itself against hundreds of Risperdal lawsuits in state and federal courts across the country.
Many of these actions have been filed by victims who are claiming that they are suffering from Risperdal gynecomastia, a condition that involves the excess development of male breast tissue and that they claim is a side effect of the medication.
These victims are seeking compensation for medical costs, pain and suffering and other expenses they say have been caused by side effects that they were not warned about.
Read more: http://www.resource4thepeople.com/defectivedrugs/risperdal.html